ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹225 Cr | ₹262 Cr | ₹136 Cr | ₹144 Cr | ₹184 Cr |
What is the latest Total Non-Current Liabilities ratio of ABBOTT INDIA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹225 Cr |
| Mar2025 | ₹262 Cr |
| Mar2024 | ₹136 Cr |
| Mar2023 | ₹144 Cr |
| Mar2022 | ₹184 Cr |
How is Total Non-Current Liabilities of ABBOTT INDIA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹225 Cr | -14.05 | |
| Mar2025 | ₹262 Cr | 92.61 | |
| Mar2024 | ₹136 Cr | -5.55 | |
| Mar2023 | ₹144 Cr | -21.80 | |
| Mar2022 | ₹184 Cr | - | |
Compare Total Non-Current Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹57,103.9 Cr | -0.1% | 1.6% | -11.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -0.1% |
1.6% |
-11.2% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses